| Literature DB >> 26169956 |
Fuguo Zhou1, Chunmin Dong1, Jason E Davis2, William H Wu2, Kristen Surrao2, Guangyu Wu1,2.
Abstract
Mitogen-activated protein kinases (MAPK) can be activated by a number of biochemical pathways through distinct signaling molecules. We have recently revealed a novel function for the Ras-like small GTPase ADP-ribosylation factor 1 (ARF1) in mediating the activation of Raf1-MEK-ERK1/2 pathway by G protein-coupled receptors [Dong C, Li C and Wu G (2011) J Biol Chem 286, 43,361-43,369]. Here, we have further defined the underlying mechanism and the possible function of ARF1-mediated MAPK pathway. We demonstrated that the blockage of ARF1 activation and the disruption of ARF1 localization to the Golgi by mutating Thr48, a highly conserved residue involved in the exchange of GDP for GTP, and the myristoylation site Gly2 abolished ARF1's ability to activate ERK1/2. In addition, treatment with Golgi structure disrupting agents markedly attenuated ARF1-mediated ERK1/2 activation. Furthermore, ARF1 significantly promoted cell proliferation. More interestingly, ARF1 activated 90kDa ribosomal S6 kinase 1 (RSK1) without influencing Elk-1 activation and ERK2 translocation to the nuclei. These data demonstrate that, once activated, ARF1 activates the MAPK pathway likely using the Golgi as a main platform, which in turn activates the cytoplasmic RSK1, leading to cell proliferation.Entities:
Keywords: ARF1; Cell proliferation; ERK1/2; G protein; G protein-coupled receptor; MAPK; RSK1
Mesh:
Substances:
Year: 2015 PMID: 26169956 PMCID: PMC4739547 DOI: 10.1016/j.cellsig.2015.06.007
Source DB: PubMed Journal: Cell Signal ISSN: 0898-6568 Impact factor: 4.315